Showing 1,626–1,650 of 7,627 international scientific journals
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1626 | Blood Research ISSN: 2287-979X / 2288-0011 | 🌐South Korea | Q2 | CAS Tier 3 | 3.7 | 0.924Q2 | — | 45 | 8.7% | Korean Society of Hematology | Profile |
| 1627 | BMC Endocrine Disorders ISSN: 1472-6823 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.7 | 1.024Q1 | 33 | 246 | 3.6% | BioMed Central | Profile |
| 1628 | BMC Medical Research Methodology ISSN: 1471-2288 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.7 | 1.426Q1 | 97 | 280 | 2.6% | BioMed Central | Profile |
| 1629 | BMC Palliative Care ISSN: 1472-684X | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 3.7 | 1.13Q1 | 32 | 189 | 12% | BioMed Central | Profile |
| 1630 | Breast Cancer ISSN: 1340-6868 / 1880-4233 | 🇯🇵Japan | Q1 | CAS Tier 3 | 3.7 | 1.036Q1 | 47 | 106 | 2.5% | Springer Japan | Profile |
| 1631 | Buildings Cities ISSN: 2632-6655 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.7 | 0.829Q1 | — | 45 | N/A | Ubiquity Press | Profile |
| 1632 | CABI Agriculture and Bioscience ISSN: 2662-4044 | 🇬🇧United Kingdom | Q1 | CAS Tier 3 | 3.7 | 0.664Q1 | — | 61 | N/A | BMC | Profile |
| 1633 | Cancer Epidemiology Biomarkers & Prevention ISSN: 1055-9965 / 1538-7755 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.7 | 1.426Q1 | 177 | 264 | 2.7% | American Association for Cancer Research Inc. | Profile |
| 1634 | Cell Transplantation ISSN: 0963-6897 / 1555-3892 | 🇺🇸United States | Q3 | CAS Tier 3 | 3.7 | 0.908Q1 | 90 | 133 | 3.1% | SAGE Publications Inc. | Profile |
| 1635 | ChemistryMethods ISSN: 2628-9725 | 🌐International | Q2 | CAS Tier 3 | 3.7 | 0.856Q1 | — | — | N/A | Updating | Profile |
| 1636 | Clinical & Experimental Metastasis ISSN: 0262-0898 / 1573-7276 | 🇳🇱Netherlands | Q2 | CAS Tier 3 | 3.7 | 1.187Q1 | 92 | 67 | 2.4% | Springer Netherlands | Profile |
| 1637 | Clinical Therapeutics ISSN: 0149-2918 / 1879-114X | 🇺🇸United States | Q2 | CAS Tier 3 | 3.7 | 1.041Q1 | 123 | 169 | 0% | Elsevier Inc. | Profile |
| 1638 | Computational Materials Science ISSN: 0927-0256 | 🇳🇱Netherlands | Q2 | CAS Tier 3 | 3.7 | 0.72Q1 | 97 | 882 | 6.5% | Elsevier | Profile |
| 1639 | Computational Urban Science ISSN: 2730-6852Diamond OA | 🌐International | Q2 | CAS Tier 3 | 3.7 | 0.815Q1 Diamond OA | — | — | N/A | Updating | Profile |
| 1640 | Corrosion Reviews ISSN: 0334-6005 / 2191-0316 | 🇬🇧United Kingdom | Q3 | CAS Tier 4 | 3.7 | 0.589Q2 | 26 | 43 | 3.7% | Walter de Gruyter GmbH | Profile |
| 1641 | Current Heart Failure Reports ISSN: 1546-9530 / 1546-9549 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.7 | 1.161Q1 | — | 41 | 2.6% | Springer Nature | Profile |
| 1642 | Current Problems in Cardiology ISSN: 0146-2806 / 1535-6280Top Tier | 🇺🇸United States | Q2 | CAS Tier 3 | 3.7 | — | 44 | 162 | 6.7% | Mosby Inc. | Profile |
| 1643 | Developmental Medicine and Child Neurology ISSN: 0012-1622 / 1469-8749Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 3.7 | 1.484Q1 | 129 | 187 | 13.2% | Wiley-Blackwell | Profile |
| 1644 | Diseases ISSN: 2079-9721 | 🇨🇭Switzerland | Q2 | CAS Tier 3 | 3.7 | 0.919Q1 | — | 86 | 3.4% | MDPI AG | Profile |
| 1645 | Drone Systems and Applications ISSN: 2564-4939 | 🌐International | Q2 | CAS Tier 4 | 3.7 | 0.519Q2 | — | — | N/A | Updating | Profile |
| 1646 | Drug Target Insights ISSN: 1177-3928 | 🌐Italy | Q2 | CAS Tier 4 | 3.7 | 0.692Q1 | — | 5 | 5% | AboutScience Srl | Profile |
| 1647 | EJNMMI Radiopharmacy and Chemistry ISSN: 2365-421X | 🇬🇧United Kingdom | Q2 | CAS Tier 4 | 3.7 | 0.752Q1 | — | 34 | 9.1% | SpringerOpen | Profile |
| 1648 | Environment Systems and Decisions ISSN: 2194-5403 / 2194-5411 | 🌐International | Q2 | — | 3.7 | 0.637Q2 | — | 49 | N/A | Springer Nature | Profile |
| 1649 | Environmental Education Research ISSN: 1350-4622 / 1469-5871 | 🇬🇧United Kingdom | Q1 | CAS Tier 2 | 3.7 | 1.24Q1 | — | 81 | 23.1% | Taylor & Francis | Profile |
| 1650 | Epigenetics ISSN: 1559-2294 / 1559-2308 | 🇺🇸United States | Q2 | CAS Tier 2 | 3.7 | 1.05Q1 | 77 | 86 | 3.4% | Landes Bioscience | Profile |